• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据第四版心肌梗死通用定义对经皮冠状动脉介入治疗后围术期心肌梗死的临床诊断方法 - 来自欧洲心脏病学会 (ESC) 急性心血管护理协会 (ACVC) 生物标志物研究组。

The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction - from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC).

机构信息

Department of Internal Medicine III - Cardiology and Angiology, Heart Center, Medical University Innsbruck, Innsbruck, Austria.

Mayo Clinic and Medical School, Rochester, MN, USA.

出版信息

Biomarkers. 2022 Jul;27(5):407-417. doi: 10.1080/1354750X.2022.2055792. Epub 2022 May 26.

DOI:10.1080/1354750X.2022.2055792
PMID:35603440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9344934/
Abstract

PURPOSE

This review intends to illustrate basic principles on how to apply the Fourth Universal Definition of Myocardial Infarction (UDMI) for the diagnosis of peri-procedural myocardial infarction (MI) after percutaneous coronary interventions (PCI) in clinical practice.

METHODS AND RESULTS

Review of routine case-based events. Increases in cardiac troponin (cTn) concentrations are common after elective PCI in patients with chronic coronary syndrome (CCS). Peri-procedural PCI-related MI (type 4a MI) in CCS patients should be diagnosed in cases of major peri-procedural acute myocardial injury indicated by an increase in cTn concentrations of >5-times the 99th percentile upper reference limit (URL) together with evidence of new peri-procedural myocardial ischaemia as demonstrated by electrocardiography (ECG), imaging, or flow-limiting peri-procedural complications in coronary angiography. Measurement of cTn baseline concentrations before elective PCI is useful. In patients presenting with acute MI undergoing PCI, peri-procedural increases in cTn concentrations are usually due to their index presentation and not PCI-related, apart from obvious major peri-procedural complications, such as persistent occlusion of a large side branch or no-reflow after stent implantation.

CONCLUSION

The distinction between type 4a MI, PCI-related acute myocardial injury, and chronic myocardial injury can be challenging in individuals undergoing PCI. Careful integration of all available clinical data is essential for correct classification.

摘要

目的

本文旨在阐述如何将第四版心肌梗死通用定义(UDMI)应用于经皮冠状动脉介入治疗(PCI)后围手术期心肌梗死(MI)的诊断,以指导临床实践。

方法和结果

回顾基于常规病例的事件。在慢性冠状动脉综合征(CCS)患者接受择期 PCI 后,心肌肌钙蛋白(cTn)浓度升高较为常见。CCS 患者的围手术期 PCI 相关 MI(4a 型 MI)应诊断为 cTn 浓度较第 99 百分位 URL 上限升高>5 倍,并伴有心电图(ECG)、影像学或冠状动脉造影显示新的围手术期心肌缺血证据的主要围手术期急性心肌损伤。在择期 PCI 前测量 cTn 基线浓度有助于诊断。对于因急性 MI 而行 PCI 的患者,cTn 浓度的围手术期升高通常归因于其首发表现,而不是 PCI 相关,除非存在明显的主要围手术期并发症,如大分支持续闭塞或支架植入后无复流。

结论

在接受 PCI 的个体中,区分 4a 型 MI、PCI 相关急性心肌损伤和慢性心肌损伤具有一定挑战性。仔细整合所有可用的临床数据对于正确分类至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/ceaf823cf0ce/IBMK_A_2055792_F0006_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/54c175e509a5/IBMK_A_2055792_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/5a6379a51299/IBMK_A_2055792_F0005_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/050bf0b5e3e6/IBMK_A_2055792_F0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/749dece1bc55/IBMK_A_2055792_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/417a6738359b/IBMK_A_2055792_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/ceaf823cf0ce/IBMK_A_2055792_F0006_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/54c175e509a5/IBMK_A_2055792_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/5a6379a51299/IBMK_A_2055792_F0005_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/050bf0b5e3e6/IBMK_A_2055792_F0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/749dece1bc55/IBMK_A_2055792_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/417a6738359b/IBMK_A_2055792_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee7/9344934/ceaf823cf0ce/IBMK_A_2055792_F0006_B.jpg

相似文献

1
The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction - from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC).根据第四版心肌梗死通用定义对经皮冠状动脉介入治疗后围术期心肌梗死的临床诊断方法 - 来自欧洲心脏病学会 (ESC) 急性心血管护理协会 (ACVC) 生物标志物研究组。
Biomarkers. 2022 Jul;27(5):407-417. doi: 10.1080/1354750X.2022.2055792. Epub 2022 May 26.
2
Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data.择期经皮冠状动脉介入治疗患者的程序性心肌损伤、梗死和死亡率:患者水平数据的汇总分析。
Eur Heart J. 2021 Jan 21;42(4):323-334. doi: 10.1093/eurheartj/ehaa885.
3
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).经皮冠状动脉介入治疗相关的围术期心肌损伤和梗死的预后相关因素:ESC 心脏细胞生物学工作组和欧洲经皮心血管介入协会(EAPCI)的共识文件。
Eur Heart J. 2021 Jul 15;42(27):2630-2642. doi: 10.1093/eurheartj/ehab271.
4
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.现行经皮冠状动脉介入治疗相关心肌梗死定义的预后和实用验证。
JACC Cardiovasc Interv. 2018 May 14;11(9):856-864. doi: 10.1016/j.jcin.2018.02.006.
5
[Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].[动态心肌肌钙蛋白I浓度和C反应蛋白在反复心肌梗死患者心肌梗死监测中的评估]
Pol Merkur Lekarski. 2010 Jun;28(168):444-9.
6
The prognosis of periprocedural myocardial infarction after percutaneous coronary interventions.经皮冠状动脉介入治疗后围手术期心肌梗死的预后
Cardiovasc Revasc Med. 2013 Jan-Feb;14(1):32-6. doi: 10.1016/j.carrev.2012.10.006. Epub 2012 Nov 17.
7
Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.围术期心肌梗死对血运重建后结局的影响。
J Am Coll Cardiol. 2020 Oct 6;76(14):1622-1639. doi: 10.1016/j.jacc.2020.08.009.
8
Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction.非ST段抬高型心肌梗死患者中4a型心肌梗死和围手术期心肌损伤的预后相关性
Circulation. 2025 Mar 18;151(11):760-772. doi: 10.1161/CIRCULATIONAHA.124.070729. Epub 2025 Feb 19.
9
Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI.经皮冠状动脉介入治疗(PCI)的慢性冠状动脉综合征患者围手术期心肌梗死(MI)的发生率及结局。
J Am Coll Cardiol. 2022 Feb 15;79(6):513-526. doi: 10.1016/j.jacc.2021.11.047.
10
Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.不同的心脏生物标志物在当代冠状动脉支架试验中检测围手术期心肌梗死:对结果报告的影响。
Heart. 2012 Oct;98(19):1424-30. doi: 10.1136/heartjnl-2012-302267. Epub 2012 Jul 21.

引用本文的文献

1
The Pathophysiology of Cardiac Troponin Release and the Various Circulating Cardiac Troponin Forms-Potential Clinical Implications.心肌肌钙蛋白释放的病理生理学及各种循环心肌肌钙蛋白形式——潜在的临床意义
J Clin Med. 2025 Jun 14;14(12):4241. doi: 10.3390/jcm14124241.

本文引用的文献

1
High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality.心脏手术后高敏肌钙蛋白 I 与 30 天死亡率。
N Engl J Med. 2022 Mar 3;386(9):827-836. doi: 10.1056/NEJMoa2000803.
2
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).经皮冠状动脉介入治疗相关的围术期心肌损伤和梗死的预后相关因素:ESC 心脏细胞生物学工作组和欧洲经皮心血管介入协会(EAPCI)的共识文件。
Eur Heart J. 2021 Jul 15;42(27):2630-2642. doi: 10.1093/eurheartj/ehab271.
3
ESC Study Group on Cardiac Biomarkers of the Association for Acute CardioVascular Care: A fond farewell at the retirement of CKMB.
欧洲心脏病学会急性心血管护理协会心脏生物标志物研究组:肌酸激酶同工酶(CKMB)退休之际的深情告别。
Eur Heart J. 2021 Jun 14;42(23):2260-2264. doi: 10.1093/eurheartj/ehaa1079.
4
Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans.短暂性诱发冠状动脉球囊阻塞后心脏肌钙蛋白 T 和 I 及 copeptin 的时间释放。
Circulation. 2021 Mar 16;143(11):1095-1104. doi: 10.1161/CIRCULATIONAHA.120.046574. Epub 2020 Dec 10.
5
Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data.择期经皮冠状动脉介入治疗患者的程序性心肌损伤、梗死和死亡率:患者水平数据的汇总分析。
Eur Heart J. 2021 Jan 21;42(4):323-334. doi: 10.1093/eurheartj/ehaa885.
6
Determinants of Periprocedural Myocardial Infarction in Current Elective Percutaneous Coronary Interventions.当前择期经皮冠状动脉介入治疗中围手术期心肌梗死的决定因素
Int Heart J. 2020 Nov 28;61(6):1121-1128. doi: 10.1536/ihj.20-215. Epub 2020 Nov 13.
7
Procedural Myocardial Infarction: Definitions Everywhere, But Not Any That May Fit.程序性心肌梗死:定义随处可见,但却没有一个适用的。
J Am Coll Cardiol. 2020 Oct 6;76(14):1640-1643. doi: 10.1016/j.jacc.2020.08.024.
8
Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.择期经皮冠状动脉介入治疗患者围术期心肌损伤的发生率、预测因素及临床意义。
J Cardiol. 2020 Sep;76(3):309-316. doi: 10.1016/j.jjcc.2020.03.008. Epub 2020 Apr 27.
9
Periprocedural elevated myocardial biomarkers and clinical outcomes following elective percutaneous coronary intervention: a comprehensive dose-response meta-analysis of 44,972 patients from 24 prospective studies.择期经皮冠状动脉介入治疗后围手术期心肌生物标志物升高与临床结局:来自 24 项前瞻性研究的 44972 例患者的综合剂量反应荟萃分析。
EuroIntervention. 2020 Mar 20;15(16):1444-1450. doi: 10.4244/EIJ-D-19-00737.
10
Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.择期冠状动脉介入治疗后心肌损伤风险较高患者的识别。
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):578-585. doi: 10.1002/ccd.28549. Epub 2019 Oct 22.